CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 40 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,000 | 0.0% | 1,984 | +103.1% | 0.00% | – |
Q1 2022 | $2,000 | -33.3% | 977 | +51.5% | 0.00% | – |
Q3 2021 | $3,000 | +50.0% | 645 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 645 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | -33.3% | 645 | 0.0% | 0.00% | – |
Q3 2020 | $3,000 | +50.0% | 645 | +6.1% | 0.00% | – |
Q2 2020 | $2,000 | +100.0% | 608 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -90.9% | 608 | -70.9% | 0.00% | -100.0% |
Q4 2019 | $11,000 | +57.1% | 2,088 | -6.0% | 0.00% | – |
Q3 2019 | $7,000 | +75.0% | 2,222 | +120.9% | 0.00% | – |
Q2 2019 | $4,000 | +300.0% | 1,006 | +241.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 295 | -0.3% | 0.00% | – |
Q4 2018 | $1,000 | -80.0% | 296 | -48.6% | 0.00% | – |
Q3 2018 | $5,000 | +400.0% | 576 | +433.3% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 108 | +10.2% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 98 | +27.3% | 0.00% | – |
Q3 2017 | $1,000 | -83.3% | 77 | -83.5% | 0.00% | -100.0% |
Q2 2017 | $6,000 | +20.0% | 466 | +110.9% | 0.00% | – |
Q1 2017 | $5,000 | – | 221 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |